Sonoma Biotherapeutics Funding & Investors
South San Francisco, CA
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.
sonomabio.comTotal Amount Raised: $365,000,000
Sonoma Biotherapeutics Funding Rounds
Corporate Round
$30,000,000
Corporate Round Investors
Regeneron PharmaceuticalsSeries B
$265,000,000
Series B Investors
Ally Bridge GroupFidelityNS InvestmentJDRF T1D FundLilly Asia VenturesArrowMark Colorado Holdings8VCVertex Ventures HCCasdin CapitalGVAvidity PartnersLifeforce CapitalArch Venture PartnersHenderson Global InvestorsAlexandria Venture InvestmentsMirae AssetDeep Track CapitalOUP (Osage University Partners)Frazier ManagementOctagon Capital AdvisorsSeries A
$30,000,000
Series A Investors
Arch Venture Partners8VCLilly Asia VenturesLyell ImmunopharmaJDRF T1D FundAlexandria Venture InvestmentsLifeforce CapitalOctagon Capital AdvisorsSeries A
$40,000,000
Series A Investors
Lyell Immunopharma8VCMilky Way VenturesArch Venture Partners
Funding info provided by Diffbot.